{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:42:02Z","timestamp":1792564922233,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patient-reported outcomes (PROs) are critical tools for measuring how patients experience their illness and treatment. Neuropsychiatric symptoms, headaches, seizures, and neurological deficits evolve over time and impact quality of life. In this narrative review, we summarize current literature on PROs in neuro-oncology, extant artificial intelligence (AI) tools for PRO analysis, considerations for real-world application, and ethical implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed\/MEDLINE, Embase, and Google Scholar for English-language articles published from January 2015 through April 2026, supplemented by reference-list reviews. Four themes were agreed upon, and authors were assigned to each theme. Authors conducted a literature review, selected articles, and synthesized the information under each of these themes. An initial 78 articles were narrowed down to 53 confirming eligibility if they reported PRO or symptom data in people with brain tumors or computational\/AI methods were applied to PRO or symptom monitoring in oncology. Article selection was verified by two senior authors (L.V.Y, A.S.). Older, foundational studies were retained where they remain the primary evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The growing volume and complexity of PRO data present challenges for traditional analysis methods. Integrating AI, including machine learning (ML) and large language models (LLMs), may help model longitudinal symptom trajectories to predict deterioration, extract symptoms from free-text clinical notes, and embed outputs in clinical decision support tools. Autonomy, informed consent, data security, bias, access, transparency and accountability should be considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Successful translation will require interpretable, electronic health record-integrated, bias-mitigating tools that allow for actionable insights and preserve patient consent, privacy, and autonomy in this highly vulnerable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-026-05832-9","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:52:19Z","timestamp":1792561939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence for symptom assessment and patient-reported outcomes in neuro-oncology"],"prefix":"10.1007","volume":"180","author":[{"given":"Lalanthica V.","family":"Yogendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chace","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C.","family":"Crooms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ozair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Guterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"5832_CR1","doi-asserted-by":"publisher","unstructured":"Taphoorn MJB, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D et al (1990) An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. Oxford, England: ; 2010;46:1033\u201340. https:\/\/doi.org\/10.1016\/j.ejca.2010.01.012","DOI":"10.1016\/j.ejca.2010.01.012"},{"issue":"1995030175","key":"5832_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/1097-0142","volume":"75","author":"MA Weitzner","year":"1995","unstructured":"Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA (1995) The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75(1995030175):1151\u20131161. https:\/\/doi.org\/10.1002\/1097-0142. :5%3C1151::aid-cncr2820750515%3E3.0.co;2-q","journal-title":"Cancer"},{"key":"5832_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-006-9135-z","volume":"80","author":"TS Armstrong","year":"2006","unstructured":"Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L et al (2006) Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol 80:27\u201335. https:\/\/doi.org\/10.1007\/s11060-006-9135-z","journal-title":"J Neurooncol"},{"key":"5832_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. J Natl Cancer Inst 85:365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"5832_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00435979","volume":"5","author":"D Osoba","year":"1996","unstructured":"Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139\u2013150. https:\/\/doi.org\/10.1007\/BF00435979","journal-title":"Qual Life Res"},{"key":"5832_CR6","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(18)30004-4","volume":"19","author":"L Dirven","year":"2018","unstructured":"Dirven L, Armstrong TS, Blakeley JO, Brown PD, Grant R, Jalali R et al (2018) Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative. Lancet Oncol 19:e173\u2013e180. https:\/\/doi.org\/10.1016\/S1470-2045(18)30004-4","journal-title":"Lancet Oncol"},{"key":"5832_CR7","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/neuonc\/noaf108","volume":"27","author":"OA Asogwa","year":"2025","unstructured":"Asogwa OA, Dirven L, Walbert T, Armstrong TS, Arons D, van den Bent MJ et al (2025) Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative. Neuro Oncol 27:2399\u20132414. https:\/\/doi.org\/10.1093\/neuonc\/noaf108","journal-title":"Neuro Oncol"},{"key":"5832_CR8","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/S1470-2045(19)30796-X","volume":"21","author":"TS Armstrong","year":"2020","unstructured":"Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C et al (2020) Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol 21:e97\u2013103. https:\/\/doi.org\/10.1016\/S1470-2045(19)30796-X","journal-title":"Lancet Oncol"},{"key":"5832_CR9","doi-asserted-by":"publisher","first-page":"101718","DOI":"10.1016\/j.eclinm.2022.101718","volume":"55","author":"E Vera","year":"2023","unstructured":"Vera E, Christ A, Grajkowska E, Briceno N, Choi A, Crandon SK et al (2023) Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort study. EClinicalMedicine 55:101718. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101718","journal-title":"EClinicalMedicine"},{"key":"5832_CR10","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/S1470-2045(13)70308-5","volume":"14","author":"NU Lin","year":"2013","unstructured":"Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R et al (2013) Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol 14:e407\u2013416. https:\/\/doi.org\/10.1016\/S1470-2045(13)70308-5","journal-title":"Lancet Oncol"},{"key":"5832_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/CCO.0000000000001078","volume":"36","author":"JCC Scheepens","year":"2024","unstructured":"Scheepens JCC, Taphoorn MJB, Koekkoek JAF (2024) Patient-reported outcomes in neuro-oncology. Curr Opin Oncol 36:560\u2013568. https:\/\/doi.org\/10.1097\/CCO.0000000000001078","journal-title":"Curr Opin Oncol"},{"key":"5832_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s13566-012-0019-x","volume":"2","author":"J Nguyen","year":"2013","unstructured":"Nguyen J, Caissie A, Zhang L, Zeng L, Dennis K, Holden L et al (2013) Dexamethasone toxicity and quality of life in patients with brain metastases following palliative whole-brain radiotherapy. J Radiat Oncol 2:435\u2013443. https:\/\/doi.org\/10.1007\/s13566-012-0019-x","journal-title":"J Radiat Oncol"},{"key":"5832_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12874-021-01259-0","volume":"21","author":"P Gebert","year":"2021","unstructured":"Gebert P, Schindel D, Frick J, Schenk L, Grittner U (2021) Characteristics and patient-reported outcomes associated with dropout in severely affected oncological patients: an exploratory study. BMC Med Res Methodol 21:77. https:\/\/doi.org\/10.1186\/s12874-021-01259-0","journal-title":"BMC Med Res Methodol"},{"key":"5832_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P et al (2016) Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. JCO 34:557\u2013565. https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"JCO"},{"key":"5832_CR15","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","volume":"327","author":"E Basch","year":"2022","unstructured":"Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM et al (2022) Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial. JAMA 327:2413. https:\/\/doi.org\/10.1001\/jama.2022.9265","journal-title":"JAMA"},{"key":"5832_CR16","doi-asserted-by":"publisher","first-page":"vdag055","DOI":"10.1093\/noajnl\/vdag055","volume":"8","author":"T Walbert","year":"2026","unstructured":"Walbert T, Shin H, Schultz L, Nerenz D, Snyder JM, Mohn DJ (2026) Electronic assessment of health-related quality of life in glioblastoma patients using the EORTC-QLQ-C30\/EORTC-BN20 and the PROMIS system in clinical practice. Neurooncol Adv 8:vdag055. https:\/\/doi.org\/10.1093\/noajnl\/vdag055","journal-title":"Neurooncol Adv"},{"key":"5832_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/nop\/npab044","volume":"8","author":"JG Ellen","year":"2021","unstructured":"Ellen JG, Boele FW, Hellman B, Duprey K, Nayak L, Morris J (2021) Pilot study of smartphone-based health outcome tracking (OurBrainBank) for glioblastoma patients. Neurooncol Pract 8:684\u2013690. https:\/\/doi.org\/10.1093\/nop\/npab044","journal-title":"Neurooncol Pract"},{"key":"5832_CR18","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/cncr.70050","volume":"131","author":"IB Riaz","year":"2025","unstructured":"Riaz IB, Khan MA, Osterman TJ (2025) Artificial intelligence across the cancer care continuum. Cancer 131:e70050. https:\/\/doi.org\/10.1002\/cncr.70050","journal-title":"Cancer"},{"key":"5832_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41687-025-00867-4","volume":"9","author":"JH Terheyden","year":"2025","unstructured":"Terheyden JH, Pielka M, Schneider T, Holz FG, Sifa R (2025) A new generation of patient-reported outcome measures with large language models. J Patient Rep Outcomes 9:34. https:\/\/doi.org\/10.1186\/s41687-025-00867-4","journal-title":"J Patient Rep Outcomes"},{"key":"5832_CR20","doi-asserted-by":"publisher","unstructured":"Karri R, Chen Y-PP, Drummond KJ (2022) Using machine learning to predict health-related quality of life outcomes in patients with low grade glioma, meningioma, and acoustic neuroma. Vellido A, editor. PLoS ONE. ;17:e0267931. https:\/\/doi.org\/10.1371\/journal.pone.0267931","DOI":"10.1371\/journal.pone.0267931"},{"key":"5832_CR21","doi-asserted-by":"publisher","first-page":"e52322","DOI":"10.2196\/52322","volume":"10","author":"N Zeinali","year":"2024","unstructured":"Zeinali N, Youn N, Albashayreh A, Fan W, Gilbertson White S (2024) Machine Learning Approaches to Predict Symptoms in People With Cancer: Systematic Review. JMIR Cancer 10:e52322. https:\/\/doi.org\/10.2196\/52322","journal-title":"JMIR Cancer"},{"key":"5832_CR22","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1016\/j.jpainsymman.2025.01.019","volume":"69","author":"M Bilal","year":"2025","unstructured":"Bilal M, Hamza A, Malik N (2025) NLP for Analyzing Electronic Health Records and Clinical Notes in Cancer Research: A Review. J Pain Symptom Manag 69:e374\u2013e394. https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.01.019","journal-title":"J Pain Symptom Manag"},{"key":"5832_CR23","doi-asserted-by":"publisher","first-page":"102701","DOI":"10.1016\/j.artmed.2023.102701","volume":"146","author":"J Sim","year":"2023","unstructured":"Sim J, Huang X, Horan MR, Stewart CM, Robison LL, Hudson MM et al (2023) Natural language processing with machine learning methods to analyze unstructured patient-reported outcomes derived from electronic health records: A systematic review. Artif Intell Med 146:102701. https:\/\/doi.org\/10.1016\/j.artmed.2023.102701","journal-title":"Artif Intell Med"},{"key":"5832_CR24","doi-asserted-by":"publisher","first-page":"e000759","DOI":"10.1136\/bmjonc-2025-000759","volume":"4","author":"D Chen","year":"2025","unstructured":"Chen D, Parsa R, Swanson K, Nunez J-J, Critch A, Bitterman DS et al (2025) Large language models in oncology: a review. bmjonc 4:e000759. https:\/\/doi.org\/10.1136\/bmjonc-2025-000759","journal-title":"bmjonc"},{"key":"5832_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/neuonc\/noaf223","volume":"28","author":"JY Rhee","year":"2026","unstructured":"Rhee JY, Tentor Z, Sounack T, Durieux B, Miller PJ, Beroukhim R et al (2026) Scalable tracking of symptoms in the electronic health record using large language models in patients with central nervous system cancers undergoing therapy. Neuro Oncol 28:206\u2013217. https:\/\/doi.org\/10.1093\/neuonc\/noaf223","journal-title":"Neuro Oncol"},{"key":"5832_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s41687-024-00808-7","volume":"8","author":"D Krepper","year":"2024","unstructured":"Krepper D, Cesari M, Hubel NJ, Zelger P, Sztankay MJ (2024) Machine learning models including patient-reported outcome data in oncology: a systematic literature review and analysis of their reporting quality. J Patient Rep Outcomes 8:126. https:\/\/doi.org\/10.1186\/s41687-024-00808-7","journal-title":"J Patient Rep Outcomes"},{"key":"5832_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12955-025-02365-z","volume":"23","author":"Z W\u00f3jcik","year":"2025","unstructured":"W\u00f3jcik Z, Dimitrova V, Warrington L, Velikova G, Absolom K (2025) Using artificial intelligence to predict patient outcomes from patient-reported outcome measures: a scoping review. Health Qual Life Outcomes 23:37. https:\/\/doi.org\/10.1186\/s12955-025-02365-z","journal-title":"Health Qual Life Outcomes"},{"key":"5832_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00520-023-07804-5","volume":"31","author":"F Menger","year":"2023","unstructured":"Menger F, Cresswell H, Lewis J, Volkmer A, Sharp L (2023) Speaking up for the lost voices: representation and inclusion of people with communication impairment in brain tumour research. Support Care Cancer 31:355. https:\/\/doi.org\/10.1007\/s00520-023-07804-5","journal-title":"Support Care Cancer"},{"key":"5832_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s41687-024-00726-8","volume":"8","author":"M Whisenant","year":"2024","unstructured":"Whisenant M, Snyder S, Weathers S-P, Bruera E, Milbury K (2024) Self and proxy symptom reporting in glioma patient-caregiver dyads: the role of psychosocial function in rating accuracy. J Patient Rep Outcomes 8:74. https:\/\/doi.org\/10.1186\/s41687-024-00726-8","journal-title":"J Patient Rep Outcomes"},{"key":"5832_CR30","doi-asserted-by":"publisher","first-page":"105317","DOI":"10.1016\/j.ijnurstu.2025.105317","volume":"175","author":"J Chi","year":"2026","unstructured":"Chi J, Zhong C, Tang J, Guo B, Zhang Y, Deng S et al (2026) Clinical Decision Support Systems for cancer symptom management: A scoping review. Int J Nurs Stud 175:105317. https:\/\/doi.org\/10.1016\/j.ijnurstu.2025.105317","journal-title":"Int J Nurs Stud"},{"key":"5832_CR31","doi-asserted-by":"publisher","first-page":"151937","DOI":"10.1016\/j.soncn.2025.151937","volume":"41","author":"ME Cooley","year":"2025","unstructured":"Cooley ME, Lenert LA, Abrahm JL, Lobach DF (2025) Using Data-driven Clinical Decision Support to Integrate Precision Cancer Symptom Management Into the Electronic Health Record. Semin Oncol Nurs 41:151937. https:\/\/doi.org\/10.1016\/j.soncn.2025.151937","journal-title":"Semin Oncol Nurs"},{"key":"5832_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41746-025-02324-4","volume":"9","author":"J Tian","year":"2026","unstructured":"Tian J, Fard P, Cagan C, Rezaii N, Rocha RB, Wang L et al (2026) An autonomous agentic workflow for clinical detection of cognitive concerns using large language models. npj Digit Med Nat Publishing Group 9:51. https:\/\/doi.org\/10.1038\/s41746-025-02324-4","journal-title":"npj Digit Med Nat Publishing Group"},{"key":"5832_CR33","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.jcpo.2025.100618","volume":"45","author":"CL Moss","year":"2025","unstructured":"Moss CL, Malpass J, Fox L, Guerrero-Urbano T, Aggarwal A, Van Hemelrijck M (2025) Implementing patient reported outcomes in cancer care: Lessons and strategies from a large UK Cancer Centre. J Cancer Policy 45:100618. https:\/\/doi.org\/10.1016\/j.jcpo.2025.100618","journal-title":"J Cancer Policy"},{"key":"5832_CR34","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1055\/a-2461-3027","volume":"8","author":"D Russell","year":"2024","unstructured":"Russell D, Sharma Y, Ambrosy AP, Axsom K, Chaiyasit JJ, Cuomo MO et al (2024) Stakeholder Perspectives on the Meaningful Integration of Clinical Informatics Interventions Using Patient-Reported Outcomes in Healthcare. ACI open 8:e79\u201388. https:\/\/doi.org\/10.1055\/a-2461-3027","journal-title":"ACI open"},{"key":"5832_CR35","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/cncr.32030","volume":"125","author":"B Yanez","year":"2019","unstructured":"Yanez B, Bouchard LC, Cella D, Sosman JA, Kircher SM, Mohindra NA et al (2019) Patient-centered engagement and symptom\/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platforms. Cancer 125:2338\u20132344. https:\/\/doi.org\/10.1002\/cncr.32030","journal-title":"Cancer"},{"key":"5832_CR36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s11136-022-03284-y","volume":"32","author":"C Xu","year":"2023","unstructured":"Xu C, Subbiah IM, Lu S-C, Pfob A, Sidey-Gibbons C (2023) Machine learning models for 180-day mortality prediction of patients with advanced cancer using patient-reported symptom data. Qual Life Res 32:713\u2013727. https:\/\/doi.org\/10.1007\/s11136-022-03284-y","journal-title":"Qual Life Res"},{"key":"5832_CR37","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jamaoncol.2020.4331","volume":"6","author":"CR Manz","year":"2020","unstructured":"Manz CR, Chen J, Liu M, Chivers C, Regli SH, Braun J et al (2020) Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer. JAMA Oncol 6:1723\u20131730. https:\/\/doi.org\/10.1001\/jamaoncol.2020.4331","journal-title":"JAMA Oncol"},{"key":"5832_CR38","doi-asserted-by":"publisher","unstructured":"Binder J, Sharma A, Ralic D, Sengupta S. Use of a patient-facing digital tool for glioblastoma outside scheduled clinic visits. J Clin Oncol.[cited 2026 Aug 25]. https:\/\/doi.org\/10.1200\/JCO.2026.44.16_suppl.1514. Accessed 25 Aug 2026","DOI":"10.1200\/JCO.2026.44.16_suppl.1514"},{"key":"5832_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/nop\/npaa040","volume":"7","author":"A Pace","year":"2020","unstructured":"Pace A, Koekkoek JAF, van den Bent MJ, Bulbeck HJ, Fleming J, Grant R et al (2020) Determining medical decision-making capacity in brain tumor patients: why and how? Neurooncol Pract 7:599\u2013612. https:\/\/doi.org\/10.1093\/nop\/npaa040","journal-title":"Neurooncol Pract"},{"key":"5832_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/02692163251409290","volume":"40","author":"JY Rhee","year":"2026","unstructured":"Rhee JY, Miller P, Tentor Z, Reich A, Wright AA, Lindvall C (2026) A qualitative study with patients, care-partners, clinicians, and bioethicists to identify ethical considerations of artificial intelligence tools in palliative care. Palliat Med 40:667\u2013677. https:\/\/doi.org\/10.1177\/02692163251409290","journal-title":"Palliat Med"},{"key":"5832_CR41","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1001\/jama.2025.18490","volume":"334","author":"DC Angus","year":"2025","unstructured":"Angus DC, Khera R, Lieu T, Liu V, Ahmad FS, Anderson B et al (2025) AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence. JAMA 334:1650\u20131664. https:\/\/doi.org\/10.1001\/jama.2025.18490","journal-title":"JAMA"},{"key":"5832_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11910-023-01314-x","volume":"23","author":"NM Michaelson","year":"2023","unstructured":"Michaelson NM, Watsula A, Bakare-Okpala A, Mohamadpour M, Chukwueke UN, Budhu JA (2023) Disparities in Neuro-Oncology. Curr Neurol Neurosci Rep 23:815\u2013825. https:\/\/doi.org\/10.1007\/s11910-023-01314-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"5832_CR43","doi-asserted-by":"publisher","first-page":"vdaa059","DOI":"10.1093\/noajnl\/vdaa059","volume":"2","author":"B Taha","year":"2020","unstructured":"Taha B, Winston G, Tosi U, Hartley B, Hoffman C, Dahmane N et al (2020) Missing diversity in brain tumor trials. Neurooncol Adv 2:vdaa059. https:\/\/doi.org\/10.1093\/noajnl\/vdaa059","journal-title":"Neurooncol Adv"},{"key":"5832_CR44","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/neuonc\/noac011","volume":"24","author":"SJ Reihl","year":"2022","unstructured":"Reihl SJ, Patil N, Morshed RA, Mehari M, Aabedi A, Chukwueke UN et al (2022) A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act. Neuro Oncol 24:1341\u20131349. https:\/\/doi.org\/10.1093\/neuonc\/noac011","journal-title":"Neuro Oncol"},{"key":"5832_CR45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/jnci\/djae240","volume":"117","author":"Y Kim","year":"2025","unstructured":"Kim Y, Armstrong TS, Gilbert MR, Celiku O (2025) Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United States. JNCI: J Natl Cancer Inst 117:511\u2013516. https:\/\/doi.org\/10.1093\/jnci\/djae240","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"5832_CR46","doi-asserted-by":"publisher","first-page":"e2144967","DOI":"10.1001\/jamanetworkopen.2021.44967","volume":"5","author":"G Himmelstein","year":"2022","unstructured":"Himmelstein G, Bates D, Zhou L (2022) Examination of Stigmatizing Language in the Electronic Health Record. JAMA Netw Open 5:e2144967. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.44967","journal-title":"JAMA Netw Open"},{"key":"5832_CR47","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s11606-021-06682-z","volume":"36","author":"MC Beach","year":"2021","unstructured":"Beach MC, Saha S, Park J, Taylor J, Drew P, Plank E et al (2021) Testimonial Injustice: Linguistic Bias in the Medical Records of Black Patients and Women. J Gen Intern Med 36:1708\u20131714. https:\/\/doi.org\/10.1007\/s11606-021-06682-z","journal-title":"J Gen Intern Med"},{"key":"5832_CR48","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/neuonc\/noaa054","volume":"22","author":"N Lamba","year":"2020","unstructured":"Lamba N, Mehanna E, Kearney RB, Catalano PJ, Haas-Kogan DA, Alexander BM et al (2020) Racial disparities in supportive medication use among older patients with brain metastases: a population-based analysis. Neuro Oncol 22:1339\u20131347. https:\/\/doi.org\/10.1093\/neuonc\/noaa054","journal-title":"Neuro Oncol"},{"key":"5832_CR49","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1200\/JCO.2015.61.6458","volume":"33","author":"RK Sharma","year":"2015","unstructured":"Sharma RK, Cameron KA, Chmiel JS, Von Roenn JH, Szmuilowicz E, Prigerson HG et al (2015) Racial\/Ethnic Differences in Inpatient Palliative Care Consultation for Patients With Advanced Cancer. J Clin Oncol 33:3802\u20133808. https:\/\/doi.org\/10.1200\/JCO.2015.61.6458","journal-title":"J Clin Oncol"},{"key":"5832_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","volume":"366","author":"Z Obermeyer","year":"2019","unstructured":"Obermeyer Z, Powers B, Vogeli C, Mullainathan S (2019) Dissecting racial bias in an algorithm used to manage the health of populations. Sci Am Association Advancement Sci 366:447\u2013453. https:\/\/doi.org\/10.1126\/science.aax2342","journal-title":"Sci Am Association Advancement Sci"},{"key":"5832_CR51","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1001\/jama.2023.22557","volume":"330","author":"R Khera","year":"2023","unstructured":"Khera R, Simon MA, Ross JS, Automation Bias, Assistive AI (2023) Risk of Harm From AI-Driven Clinical Decision Support. JAMA 330:2255\u20132257. https:\/\/doi.org\/10.1001\/jama.2023.22557","journal-title":"JAMA"},{"key":"5832_CR52","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1177\/09697330241296874","volume":"32","author":"O Oh","year":"2025","unstructured":"Oh O, Demiris G, Ulrich CM (2025) The ethical dimensions of utilizing Artificial Intelligence in palliative care. Nurs Ethics 32:1285\u20131296. https:\/\/doi.org\/10.1177\/09697330241296874","journal-title":"Nurs Ethics"},{"key":"5832_CR53","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/neuonc\/noae127","volume":"26","author":"M Mehari","year":"2024","unstructured":"Mehari M, Sibih Y, Dada A, Chang SM, Wen PY, Molinaro AM et al (2024) Enhancing neuro-oncology care through equity-driven applications of artificial intelligence. Neuro Oncol 26:1951\u20131963. https:\/\/doi.org\/10.1093\/neuonc\/noae127","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05832-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:52:20Z","timestamp":1792561940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05832-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5832"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05832-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"6 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jason Binder is founder of an AI tool that engages with and provides support to patients and care partners living with cancer (Ember Health AI), and discusses its work.Akanksha Sharma, MD is a guest editor for this special issue.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26"}}